Holen Sie sich die Stockscreener-App
1.17
4.88%
-0.06
Handel nachbörslich:
1.18
0.01
+0.85%
Schlusskurs vom Vortag:
$1.23
Offen:
$1.24
24-Stunden-Volumen:
3.95M
Relative Volume:
0.66
Marktkapitalisierung:
$751.69M
Einnahmen:
$196.12M
Nettoeinkommen (Verlust:
$-69.59M
KGV:
-11.22
EPS:
-0.1043
Netto-Cashflow:
$-126.13M
1W Leistung:
-4.49%
1M Leistung:
-9.30%
6M Leistung:
-30.77%
1J Leistung:
-4.88%
1-Tages-Spanne:
$1.17
$1.24
1-Wochen-Bereich:
$1.17
$1.24
52-Wochen-Spanne:
$1.04
$2.01
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.17 | 751.69M | 196.12M | -69.59M | -126.13M | -0.1043 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Sell |
| 2025-05-08 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Eingeleitet | TD Cowen | Buy |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-28 | Eingeleitet | Goldman | Neutral |
| 2022-10-28 | Eingeleitet | Wedbush | Outperform |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-08-03 | Eingeleitet | Stifel | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Hochstufung | Needham | Hold → Buy |
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform |
| 2016-09-13 | Bestätigt | FBR Capital | Outperform |
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
| 2013-12-10 | Bestätigt | MLV & Co | Buy |
| 2013-12-10 | Hochstufung | Needham | Hold → Buy |
| 2013-11-08 | Bestätigt | MLV & Co | Buy |
| 2013-10-16 | Eingeleitet | MLV & Co | Buy |
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia - Yahoo Finance
In a 58-patient U.S. study, about 67% remained on Geron's treatment at six months. - Stock Titan
Geron Q2 2026 Earnings Call: Complete Transcript - Benzinga
Can Reblozyl Power Bristol Myers' Top-Line Growth Going Forward? - Zacks Investment Research
Shares replace cash fees for Geron (GERN) director Robert J. Spiegel, who acquired 6,351 shares. - Stock Titan
Law firm investigates Geron Corp officers for p... - Pluang
Law firm investigates Geron Corp over alleged m... - Pluang
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron CorporationGERN - Morningstar
Why Did GERN Stock Tumble 10% Pre-Market Today? - Stocktwits
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands - Yahoo Finance
GERN News | GERON CORP (NASDAQ:GERN) - ChartMill
Geron at cantor healthcare conference: RYTELO growth, profit path By Investing.com - Investing.com South Africa
Geron at cantor healthcare conference: RYTELO growth, profit path - Investing.com
Geron (GERN) Institutional Ownership 2026 - MarketBeat
Geron to Present at Upcoming Investor Conferences - Yahoo Finance
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
Edmond DE Rothschild Holding S.A. Buys New Holdings in Geron Corporation $GERN - MarketBeat
Geron (GERN) After Earnings And New RYTELO Guidance Has The Valuation Story Changed - simplywall.st
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corp.: Management's Plan Taking Shape As Competition Heats Up In Myelofibrosis - Seeking Alpha
RA Capital reports 66.5M-share Geron (GERN) position capped at 9.99% ownership - Stock Titan
Geron (NASDAQ:GERN) Stock Price Down 5.2%Here's Why - MarketBeat
GERN|Geron Corp|Price:1.530|Chg%:-0.040 - TradingKey
Geron CorporationCommon Stock (NQ: GERN - FinancialContent
Geron (NASDAQ:GERN) Shares Up 6.4%Here's What Happened - MarketBeat
Geron Corporation $GERN Stake Raised by Renaissance Technologies LLC - MarketBeat
Geron (GERN) Stock Looks Reasonable On Sales But Weak On Returns - Yahoo Finance
Geron (GERN) Back In Focus As Fresh Guidance And Earnings Test Its Undervalued Narrative - Yahoo Finance
Geron (GERN) Is Up 14.7% After Issuing First RYTELO Revenue Guide And Narrowing LossesHas The Bull Case Changed? - Yahoo Finance
Geron (GERN) Stock May Still Be Below Fair Value On Sales - simplywall.st
Geron Corporation Stock (GERN) Opinions on Recent Price Surge and Trial Updates - Quiver Quantitative
Janus Henderson Group PLC Raises Position in Geron Corporation $GERN - MarketBeat
Geron Stock Price Forecast. Should You Buy GERN? - StockInvest.us
Geron Corporation Stock (GERN) Opinions on Recent Price Surge and Trial Updates - quiverquant.com
State Street Corporation (GERN) discloses 5.6% beneficial stake in Geron - Stock Titan
HC Wainwright Issues Pessimistic Forecast for Geron Earnings - MarketBeat
Form 8K Geron Corporation For: 6 August By Investing.com - Investing.com South Africa
Form 8K Geron Corporation For: 6 August By Investing.com - Investing.com Nigeria
Is Geron Corp (GERN) on the Right Path After Q2 Earnings Report? - GuruFocus
Form 8K Geron Corporation For: 6 August By Investing.com - Investing.com India
Form 8K Geron Corporation For: 6 August By Investing.com - Investing.com Canada
Geron reports Q2 2026 RYTELO revenue $57.5M; net loss $16.7M; cash $327M - TradingView
Geron (NASDAQ:GERN) Posts Earnings Results, Misses Expectations By $0.01 EPS - marketbeat.com
Geron Corporation (GERN) stock price, news, quote and history - Yahoo Finance Singapore
GERON CORP 2026: Revenue $57.48M, EPS ($0.02) — 10-Q Summary - TradingView
[10-Q] GERON CORP Quarterly Earnings Report - Stock Titan
Geron earnings missed by $0.01, revenue topped estimates - Investing.com
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Geron Corp-Aktie (GERN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER |
Feb 18 '26 |
Sale |
1.94 |
9,855 |
19,119 |
17,645 |
| JAMES ZIEGLER | Officer |
Dec 15 '25 |
Proposed Sale |
1.37 |
20,000 |
27,400 |
0 |
2.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):